A Second-Opinion Program for the Care of Youths Prescribed Five or More Psychotropics in Washington State.
A Second-Opinion Program for the Care of Youths Prescribed Five or More Psychotropics in Washington State.
复制标题
华盛顿州一项针对青少年护理的第二意见计划规定了五种或更多精神药物。
DOI：
10.1176/appi.ps.202000234
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Hilt,RobertJ
中科院分区：
文献类型：
--
作者：
Barclay,RebeccaP;Dillon-Naftolin,Erin;Russell,Douglas;Hilt,RobertJ
这项回溯性研究描述了一项针对华盛顿州儿童护理的第二意见审查计划，这些儿童接受了医疗补助，并主要由精神健康专家开了五种或五种以上的精神药物。这项研究总共纳入了2013年的136篇第二意见评论和2018年的169篇第二意见评论。注意力缺陷多动障碍(ADHD)、行为困难、焦虑和创伤在这些儿童中普遍存在，参与者通常被开出ADHD药物、选择性5-羟色胺再摄取抑制剂和第二代抗精神病药物。回顾的发生率在这两个时期保持稳定，但心理社会治疗在这段时间内显著增加。这项研究阐明了多药物精神药物疗法的启动、维持和识别，并强调了心理社会治疗作为一种干预措施，增加了对高危患者的最佳实践护理。
This retrospective study describes a second-opinion review program for the care of children in Washington State who received Medicaid coverage and who were prescribed five or more psychotropic medications, primarily by mental health specialists. In total, 136 second-opinion reviews from 2013 and 169 from 2018 were included in this study. Attention-deficit hyperactivity disorder (ADHD), behavioral difficulties, anxiety, and trauma were prevalent among these children, and participants were commonly prescribed ADHD medications, selective serotonin reuptake inhibitors, and second-generation antipsychotics. The incidence of reviews remained stable over the two periods, but psychosocial treatment increased significantly over this time. This study sheds light on the initiation, maintenance, and identification of polypharmacy psychotropic regimens and highlights psychosocial treatment as an intervention that increases best practice care for at-risk patients.